Conjugated estrogens and medroxyprogesterone and Ranibizumab Intraocular
Determining the interaction of Conjugated estrogens and medroxyprogesterone and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: conjugated estrogens / medroxyprogesterone
Brand name: Premphase, Prempro
Synonyms: Estrogens (Conjugated/Equine) and Medroxyprogesterone
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conjugated estrogens and medroxyprogesterone-Ranibizumab ophthalmic
- Conjugated estrogens and medroxyprogesterone-Ranitidine
- Conjugated estrogens and medroxyprogesterone-Ranitidine Capsule
- Conjugated estrogens and medroxyprogesterone-Ranitidine Hydrochloride
- Conjugated estrogens and medroxyprogesterone-Ranitidine Injection
- Conjugated estrogens and medroxyprogesterone-Ranitidine Suspension
- Ranibizumab Intraocular-Conjugated estrogens and medroxyprogesterone Oral
- Ranibizumab Intraocular-Conjugated Estrogens Injection
- Ranibizumab Intraocular-Conjugated estrogens Intravenous
- Ranibizumab Intraocular-Conjugated estrogens synthetic a
- Ranibizumab Intraocular-Conjugated estrogens synthetic b
- Ranibizumab Intraocular-Conjugated Estrogens Tablets